Enzyme Alterable Alkylating Agents. V. Design of Sulfur Mustards With Varying Degrees of Hydrolytic Stability in a Search for Short Biological Half-Life Agents2
- 1 August 1963
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 31 (2) , 273-296
- https://doi.org/10.1093/jnci/31.2.273
Abstract
Short-lived alkylating agents may find application in intra-arterial chemotherapy. By proper selection of the alkylating agent, it might be possible to design agents that exert their activity within the tumors but degrade rapidly to nontoxic products in the short time required to pass through the capillary bed and return to the lungs and heart. The sulfur mustards lend themselves readily to structural variations, and a detailed analysis of the rates of hydrolysis leading to detoxification of the mustards has improved understanding of the structural factors responsible for rapid or slow hydrolysis of the carbon-to-chlorine bonds. The Taft equation was useful in relating the reactivity of sulfur mustards to some function of their structure. The rate of hydrolysis at the carbon-to-chlorine bond is influenced primarily by the nature of the polar substituents attached to the sulfur atom. Electron-withdrawing groups adjacent to the sulfur atom retard the rate of hydrolysis, while electron-donating groups in the same position result in rate acceleration. The introduction in the molecule of methylene groups between the polar substituent and the sulfur atom will minimize these effects. Based on these considerations, sulfur mustards containing β-chloroethyl groups can be designed with half lives as short as 5 to 10 seconds and as long as 5 hours or more.Keywords
This publication has 6 references indexed in Scilit:
- Enzyme-alterable alkylating agents. I. Synthesis, chemical properties, and toxicities of sulfur mustards containing enzyme-susceptible amide bondsCancer, 1962
- Enzyme-alterable alkylating agents. III. Synthesis, chemical properties, and toxicities of mustards containing enzyme-susceptible ester bondsCancer, 1962
- The reaction of mono- and di-functional alkylating agents with nucleic acidsBiochemical Journal, 1961
- Massive Nitrogen Mustard Therapy in Hodgkin’s Disease with Protection of Bone Marrow by TourniquetsBlood, 1960
- Autologous Bone Marrow Infusion as an Adjunct in Therapy of Malignant DiseaseBlood, 1959
- THE MECHANISM OF DRUG ACTION AT RECEPTOR SURFACES .1. INTRODUCTION - A GENERAL INTERPRETATION OF THE ADRENERGIC BLOCKING ACTIVITY OF BETA-HALOALKYLAMINES1958